P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification

By Chan Lauretta M.S.   Cooper Anne E.   Dudley Adam L.J.   Ford Dianne   Hirst Barry H.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe   Schmitz Volker   Haschke Manuel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite

Maximal Inhibition of Intestinal First-Pass Metabolism as a Pragmatic Indicator of Intestinal Contribution to the Drug-Drug Interactions for CYP3A4 Cleared Drugs

By  

Current Drug Metabolism, Vol. 8, Iss. 7, 2007-10 ,pp. : 685-693

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite